RS
ALLO icon

R Squared’s Allogene Therapeutics ALLO Stock Holding History

R Squared’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110K Sell
45,245
-40,970
-48% -$82.1K 0.06% 357
2025
Q4 		$118K Buy
86,215
+24,842
+40% +$32.8K 0.06% 399
2025
Q3 		$76.1K Buy
61,373
+28,860
+89% +$34.4K 0.03% 453
2025
Q2 		$36.7K Buy
+32,513
New +$43.2K 0.02% 412
2025
Q1 		– Sell
-110
Closed -$234 – 335
2024
Q4 		$234 Buy
+110
New +$271 ﹤0.01% 1555

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return